Medelis Adds NFCR COO and CSO to Medical
Advisory Board
March 23, 2005: Medelis announced the addition of the National Foundation for Cancer Research's Chief Operating Officer and Chief Scientific Officer, Dr. Sujuan Ba, to the Medelis Medical Advisory Board.
"Dr. Ba is both an excellent scientist and an accomplished business person who understands our industry in this country as well as in Europe and Asia," said Dr. David L. Edwards, President and CEO of Medelis. "She brings great international breadth to our Advisory Board."
Michael Lechter Joins Medelis Advisory Board
September 15, 2004: Medelis today announced the addition of Michael Lechter, Esq. to the Medelis Advisory Board. Mr. Lechter will assist Medelis to protect the intellectual property it develops as it pioneers new methods for taking clients drugs to market.
Medelis Completes Medical Team
March 22, 2004: Medelis announces that two more top oncologists have joined the company's Medical Advisory Board: Mace L. Rothenberg, M.D. and Howard "Skip" Burris III, M.D.
"The Medelis Medical Team is comprised of the thought and opinion leaders in oncology and oncology drug development today," said Dr. David L. Edwards, Chairman and CEO of Medelis. "The value they bring to our clients is the ability to plan clinical trials to provide the best chance of drug approval moving forward."
Medelis Announces Medical Team
December 5, 2003: Medelis brings aboard the oncology thought and opinion leaders of today.
« Return to recent news
RSS Feeds
